Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

203641 BMP-2, Human, Recombinant, E. coli

203641
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Spec Table

Purity
≥95% by SDS-PAGE

Products

Catalogue NumberPackaging Qty/Pack
203641-2UG Plastic ampoule 2 μg
Description
OverviewRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
Catalogue Number203641
Brand Family Calbiochem®
SynonymsBone morphogenetic protein 2 precursor, BMP-2A
References
ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
Morin, R., et al. 2006. Biomacromolecules 7, 131.
Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
Product Information
FormLyophilized
FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by SDS-PAGE
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage -20°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

BMP-2, Human, Recombinant, E. coli SDS

Title

Safety Data Sheet (SDS) 

BMP-2, Human, Recombinant, E. coli Certificates of Analysis

TitleLot Number
203641

References

Reference overview
Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
Morin, R., et al. 2006. Biomacromolecules 7, 131.
Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision20-May-2008 RFH
SynonymsBone morphogenetic protein 2 precursor, BMP-2A
DescriptionRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
FormLyophilized
FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
Purity≥95% by SDS-PAGE
SolubilityReconstitute to ≥100 µg/ml with 20 mM acetic acid containing 0.1% HSA or BSA. Further dilutions can be made in aqueous buffers just prior to use.
Storage -20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
Toxicity Standard Handling
ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
Morin, R., et al. 2006. Biomacromolecules 7, 131.
Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.